← Return to My Mets Breast Cancer Story: Questions about Low WBC, spots on liver

Discussion
Comment receiving replies
Profile picture for maliamd @maliamd

Hello All, Diagnosed 3 months ago with breast cancer met to several bone areas. Was dx with breast ca 4 years ago. Very small, HR+, no lymph node involvement. Lumpectomy and rad. Placed on aromatose inhibitors. Needless to say was a shock to hear about the spread which was found as an incidental finding for a lower spine x-ray. Very active, runner, healthy lifestyle and a RN. Treatment for this bone met Ibrance, Zometa, an d Fulvestrant. Feel good. Minimal side effects. Repeat PET scan this week to see how it is going. Bone hot spots responding well to treatment. One hot spot gone. One hot spot hotter. The scan did show a very small minimally active spot on my liver. Question to y'all....what are the treatment options for the very small liver spot?

Jump to this post


Replies to "Hello All, Diagnosed 3 months ago with breast cancer met to several bone areas. Was dx..."

@maliamd, I moved your 2 discussions into one so that members can follow your story and have all the details. I'm glad that you have confidence in your team. You're quite right that many factors go into creating an individualized treatment plan.

About HER2 positive breast cancer, I found this excerpt from an article from Mayo Clinic (https://www.mayoclinic.org/breast-cancer/expert-answers/faq-20058066)
"Treatments that specifically target HER2 are very effective. These treatments are so effective that the prognosis for HER2-positive breast cancer is actually quite good.
...
Whenever breast cancer recurs or spreads, the cancer cells should be retested for HER2 as well as for hormone receptor status, as these can change from the original diagnosis."

Maliamd, was the HER2 status of your diagnosis detected at the initial diagnosis of IDC 4 years ago or only with the detection of recent metastasis? Have anti-HER2 drugs been discussed as a treatment option? I look forward to hearing what you learn after this week's round of imaging.